Dova pharmaceuticals inc. (DOVA)
Balance Sheet / Yearly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Dec'16
ASSETS
Current assets
Cash and equivalents

68,400

76,782

92,703

104,566

122,027

134,695

126,897

94,846

100,414

24,762

28,709

Accounts receivables, net

-

-

-

-

-

-

-

0

-

-

-

Accounts receivable, net

1,244

3,154

225

612

2,962

3,409

-

-

-

-

-

Inventory, net

4,683

4,167

4,310

4,390

1,781

563

-

0

-

-

-

Prepaid expenses and other current assets

2,850

1,496

1,892

2,239

3,041

2,343

1,665

1,471

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

998

107

37

Total current assets

77,225

85,599

99,130

111,807

129,811

141,010

128,562

96,317

101,412

24,869

28,746

Furniture and equipment, net

579

343

362

362

278

257

188

62

35

34

-

Operating lease asset

1,146

1,240

1,336

0

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

1,510

-

Total assets

78,950

87,182

100,828

112,169

130,089

141,267

128,750

96,379

101,447

26,413

28,746

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable

1,859

2,546

468

781

68

1,542

431

1,263

585

689

157

Accrued expenses

10,920

9,063

12,139

11,935

12,997

7,409

3,169

2,520

5,451

4,079

7,918

Accrued interest

182

129

73

79

75

76

-

1,005

631

295

151

Due to related party

0

17

17

35

0

-

4

97

50

50

85

Current portion of operating lease liability

338

323

338

0

-

-

-

-

-

-

-

Early exercise liability, related party

-

-

-

-

0

-

-

100

-

-

-

Other current liabilities

-

-

-

-

-

-

44

-

-

-

-

Note payable, short-term

-

-

-

-

0

-

-

30,212

27,119

24,817

-

Current portion of long-term debt

1,913

1,177

9,167

6,667

4,166

1,667

-

0

-

-

-

Current portion of deferred revenue

-

1,920

-

-

-

-

-

-

-

-

-

Total current liabilities

15,212

15,175

22,202

19,497

17,306

10,694

3,648

35,197

33,836

29,930

8,311

Deferred revenue

453

453

2,373

2,373

2,373

2,373

-

0

-

-

-

Long-term operating lease liability

1,123

1,222

1,287

0

-

-

-

-

-

-

-

Long-term debt

28,924

19,524

11,674

13,941

16,212

18,483

-

-

-

-

-

Long-term debt

-

-

-

-

-

-

-

0

-

-

13,640

Total liabilities

45,712

36,374

37,536

35,811

35,891

31,550

3,648

35,197

33,836

29,930

21,951

Commitments and contingencies

-

-

-

-

0

0

0

-

0

0

0

Stockholders’ equity
Undesignated preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively

0

0

0

0

0

0

0

-

-

-

-

Common stock, $0.001 par value; 100,000,000 shares authorized; 28,821,405 and 28,204,098 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively

29

29

28

28

28

28

28

26

26

17

17

Additional paid-in capital

217,364

213,649

209,070

205,757

204,264

200,261

195,989

118,301

115,429

34,586

33,967

Accumulated deficit

-184,200

-162,900

-145,806

-129,427

-110,094

-90,572

-70,915

-57,145

-47,844

-38,121

-27,190

Total stockholders’ equity

33,238

50,808

63,292

76,358

94,198

109,717

125,102

61,182

67,611

-3,517

6,795

Total liabilities and stockholders’ equity

78,950

87,182

100,828

112,169

130,089

141,267

128,750

96,379

101,447

26,413

28,746